001     137278
005     20210129211954.0
024 7 _ |a 10.1016/j.vetmic.2013.05.021
|2 doi
024 7 _ |a 0378-1135
|2 ISSN
024 7 _ |a 1873-2542
|2 ISSN
024 7 _ |a WOS:000322848100011
|2 WOS
024 7 _ |a altmetric:1632692
|2 altmetric
024 7 _ |a pmid:23845735
|2 pmid
037 _ _ |a FZJ-2013-03735
041 _ _ |a English
082 _ _ |a 630
100 1 _ |a Bannach, O.
|0 P:(DE-Juel1)157832
|b 0
|u fzj
|e Corresponding author
245 _ _ |a Analysis of prion protein aggregates in blood and brain from pre-clinical and clinical BSE cases
260 _ _ |a Amsterdam [u.a.]
|c 2013
|b Elsevier Science
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1377162146_20433
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
500 _ _ |3 POF3_Assignment on 2016-02-29
520 _ _ |a Prion diseases are infectious neurodegenerative diseases affecting humans and animals. The food-borne bovine spongiform encephalopathy (BSE) had serious impact on both economy and public health, respectively. To follow the pathogenesis of BSE, oral challenge studies were previously conducted, among others on the Isle of Riems, Germany (Balkema-Buschmann et al., 2011b). In the present work brain and plasma samples from this pathogenesis study were subjected to surface fluorescence distribution analysis (sFIDA). sFIDA is a diagnostic tool that exploits the aggregated state of the disease-related prion protein (PrP) as a biomarker for prion disorders. With the exception of one animal, all tested brain samples from clinical cattle exhibited a high titer of PrP particles. Moreover we could detect PrP aggregates already 16 and 24 months after infection. In contrast to our previous demonstration of PrP particles in blood plasma from scrapie sheep, however, no aggregates could be identified in plasma from pre-clinical and clinical cattle. This is in accordance with other studies suggesting a restriction of the BSE infection to the central nervous system.
536 _ _ |a 452 - Structural Biology (POF2-452)
|0 G:(DE-HGF)POF2-452
|c POF2-452
|x 0
|f POF II
588 _ _ |a Dataset connected to CrossRef, juser.fz-juelich.de
700 1 _ |a Reinartz, E.
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Henke, F.
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Dreßen, F.
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Oelschlegel, A.
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Kaatz, M.
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Groschup, M. H.
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Willbold, D.
|0 P:(DE-Juel1)132029
|b 7
|u fzj
700 1 _ |a Riesner, D.
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Birkmann, E.
|0 P:(DE-Juel1)131992
|b 9
|u fzj
773 _ _ |a 10.1016/j.vetmic.2013.05.021
|g Vol. 166, no. 1-2, p. 102 - 108
|p 102 - 108
|n 1-2
|0 PERI:(DE-600)1498996-7
|t Veterinary microbiology
|v 166
|y 2013
|x 0378-1135
856 4 _ |u http://ac.els-cdn.com/S0378113513003039/1-s2.0-S0378113513003039-main.pdf?_tid=c4e03f74-0afd-11e3-a1a3-00000aab0f01&acdnat=1377157259_ec0b08dac1cbabf13dd3ffcba9d6272d
856 4 _ |u https://juser.fz-juelich.de/record/137278/files/FZJ-2013-03735.pdf
|y Restricted
909 C O |o oai:juser.fz-juelich.de:137278
|p VDB
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)157832
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 7
|6 P:(DE-Juel1)132029
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 9
|6 P:(DE-Juel1)131992
913 2 _ |a DE-HGF
|b Key Technologies
|l BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences
|1 G:(DE-HGF)POF3-550
|0 G:(DE-HGF)POF3-559H
|2 G:(DE-HGF)POF3-500
|v Addenda
|x 0
913 1 _ |a DE-HGF
|b Schlüsseltechnologien
|1 G:(DE-HGF)POF2-450
|0 G:(DE-HGF)POF2-452
|2 G:(DE-HGF)POF2-400
|v Structural Biology
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF2
|l BioSoft
914 1 _ |y 2013
915 _ _ |a JCR/ISI refereed
|0 StatID:(DE-HGF)0010
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1060
|2 StatID
|b Current Contents - Agriculture, Biology and Environmental Sciences
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)ICS-6-20110106
|k ICS-6
|l Strukturbiochemie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)ICS-6-20110106
981 _ _ |a I:(DE-Juel1)IBI-7-20200312


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21